2 terminated, 1 completed, 1 enrolling by invitation, 1 recruiting. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Terminated 2, Completed 1, Enrolling by invitation 1, Recruiting 1 |
Follow Malignant Ascites: new trials by email Literature Review of Malignant Ascites trials Research Report on Malignant Ascites
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis) At-home Paracentesis - Malignant Ascites | Not applicable | Recruiting | University of Utah | 20 | 2026-09-15 | 2026-09-18 |
| Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites Nivolumab, Pembrolizumab - Malignant Ascites | Not applicable | Enrolling by invitation | China Medical University Hospital | 30 | 2021-01-01 | 2023-08-24 |
| Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics Paracentesis - Malignant Ascites, Ovarian Cancer | Not applicable | Completed | Charite University, Berlin, Germany | 61 | 2017-08-01 | 2020-12-08 |
| An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites paracentesis, Pleurx catheter - Malignant Ascites | Not applicable | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 | 2010-02-01 | 2015-10-29 |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer etanidazole, therapeutic conventional surgery, laboratory biomarker analysis - Advanced Malignant Mesothelioma, Localized Malignant Mesothelioma | Not applicable | Terminated | National Cancer Institute (NCI) | 80 | 2001-10-01 | 2013-01-16 |
Mesothelioma, Malignant (1) · Ovarian Neoplasms (1)
Neoplasms (2) · Neoplasms by Site (2) · Adenoma (1) · Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Lung Diseases (1) · Lung Neoplasms (1) · Mesothelioma (1)
Paracentesis (2) · Etanidazole (1) · Nivolumab (1) · pembrolizumab (1)
Charite University, Berlin, Germany (1) · China Medical University Hospital (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University of Utah (1)
United States (3) · Germany (1) · Taiwan (1)
Anna Beck, MD (1) · Klaus Pietzner, MD (1) · Li-Yuan Bai (1) · Stephen Michael Hahn (1)
P01CA087971 (1)